Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice

Biotechnology Advances - Tập 30 - Trang 310-320 - 2012
Feroz Akhtar1,2, M. Moshahid Alam Rizvi3, Santosh Kumar Kar1
1School of Biotechnology, Jawaharlal Nehru University, New Delhi, 110067, India
2Department of Biosciences, Jamia Millia Islamia, New Delhi-110025, India.
3Department of Biosciences, Jamia Millia Islamia, New Delhi 110025, India

Tài liệu tham khảo

Aggarwal, 2009, Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets, Trends Pharmacol Sci, 30, 85, 10.1016/j.tips.2008.11.002 Aggarwal, 2007, Curcumin: the Indian solid gold, Adv Exp Med Biol, 595, 1, 10.1007/978-0-387-46401-5_1 Anand, 2007, Bioavailability of curcumin: problems and promises, Mol Pharm, 4, 807, 10.1021/mp700113r Anitha, 2011, Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles, Carbohydr Polymers, 10.1016/j.carbpol.2011.01.005 Artursson, 1994, Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2), Pharm Res, 11, 1358, 10.1023/A:1018967116988 Baudner, 2002, Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles, Infect Immun, 70, 4785, 10.1128/IAI.70.9.4785-4790.2002 Bentzen, 2007, Curcumin induced suicidal erythrocyte death, Cell Physiol Biochem, 19, 153, 10.1159/000099203 Bisht, 2007, Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy, J Nanobiotechnol, 5, 3, 10.1186/1477-3155-5-3 Borchard, 1996, The potential of mucoadhesive polymers in enhancing intestinal peptide drus absorption. III: effect of chitosan glutamate and carbomer on epithelial tight junctionsin vitro, J Control Release, 39, 131, 10.1016/0168-3659(95)00146-8 Calvo, 1997, Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers, J Appl Polym Sci, 63, 125, 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 Chou, 1992, Heme polymerase: modulation by chloroquine treatment of a rodent malaria, Life Sci, 51, 2073, 10.1016/0024-3205(92)90158-L Dodane, 1999, Effect of chitosan on epithelial permeability and structure, Int J Pharm, 182, 21, 10.1016/S0378-5173(99)00030-7 Dondorp, 2009, Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, 361, 455, 10.1056/NEJMoa0808859 Hu, 2007, Hollow chitosan/poly(acrylic acid) nanospheres as drug carriers, Biomacromolecules, 8, 1069, 10.1021/bm0608176 Jaganathan, 2005, Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(d,l-lactic-co-glycolic acid) versus chitosan microspheres, Int J Pharm, 294, 23, 10.1016/j.ijpharm.2004.12.026 Kamble Vishvajit, 2010, Nanosuspension a novel drug delivery system, Int J Pharm Bio Sci, 1, 352 Kunwar, 2006, Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study, Biochim Biophys Acta, 1760, 1513, 10.1016/j.bbagen.2006.06.012 Lao, 2006, Dose escalation of curcuminoid formulation, BMC Complement Altern Med, 6, 10, 10.1186/1472-6882-6-10 Lee, 1998, Enzymatic barriers to peptide and protein absorption, CRC Crit Rev Ther Drug Carrier Syst, 5, 69 Leung, 2009, Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen, Langmuir, 25, 5773, 10.1021/la804215v Ma, 2002, Formulation pH modulates the interaction of insulin with chitosan nanoparticles, J Pharm Sci, 91, 1396, 10.1002/jps.10149 Maheshwari, 2006, Multiple biological activities of curcumin: a short review, Life Sci, 78, 2081, 10.1016/j.lfs.2005.12.007 May, 2005, Detection and quantitation of curcumin in mouse lung cell cultures by matrix-assisted laser desorption ionization time of flight mass spectrometry, Anal Biochem, 337, 62, 10.1016/j.ab.2004.10.037 Orjih, 1993, Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine, Biochim Biophys Acta, 1157, 270, 10.1016/0304-4165(93)90109-L Pan, 1999, Biotransformation of curcumin through reduction and glucuronidation in mice, Drug Metab Dispos, 27, 486 Panyam, 2002, Rapid endo-lysosomal escape of poly(d,l-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery, FASEB J, 16, 1217, 10.1096/fj.02-0088com Priyadarsini, 2009, Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells, J Photochem Photobiol C: Photochem Rev, 10, 81, 10.1016/j.jphotochemrev.2009.05.001 Reddy, 2005, Curcumin for malaria therapy, BBRC, 326, 472 Salmaso, 2007, New cyclodextrin bioconugates for active tumor targeting, J Drug Target, 15, 379, 10.1080/10611860701349752 Shankar, 1980, Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys, Indian J Exp Biol, 18, 73 Sharma, 2007, Pharmacokinetics and pharmacodynamics of curcumin, Adv Exp Med Biol, 595, 453, 10.1007/978-0-387-46401-5_20 Sirawaraporn, 1998, Dihydrofolate reductase and antifolate resistance in malaria, Drug Resist Updat, 1, 397, 10.1016/S1368-7646(98)80015-0 Sneharani, 2009, Interaction of alphaS1-casein with curcumin and its biological implications, J Agric Food Chem, 57, 10386, 10.1021/jf902464p Sou, 2008, Loading of curcumin into macrophages using lipid-based nanoparticles, Int J Pharm, 352, 287, 10.1016/j.ijpharm.2007.10.033 Tiyaboonchai, 2007, Formulation and characterization of curcuminoids loaded solid lipid nanoparticles, Int J Pharm, 337, 299, 10.1016/j.ijpharm.2006.12.043 Trang, 2006, Inhibition assay of beta-hematin formation initiated by lecithin for screening new antimalarial drugs, Anal Biochem, 349, 292, 10.1016/j.ab.2005.11.022 Van der Lubben, 2003, Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice, Vaccine, 21, 1400, 10.1016/S0264-410X(02)00686-2 Vemula, 2006, Enzyme catalysis: tool to make and break amygdalin hydrogelators from renewable resources: a delivery model for hydrophobic drugs, J Am Chem Soc, 128, 8932, 10.1021/ja062650u Vila, 2004, Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice, Eur J Pharm Biopharm, 57, 123, 10.1016/j.ejpb.2003.09.006 Vinagradov, 2002, Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells, Adv Drug Del Rev, 54, 223 Wang, 1997, Stability of curcumin in buffer solutions and characterization of its degradation products, Pharm Biomed Anal, 15, 1867, 10.1016/S0731-7085(96)02024-9 Winstanley, 2000, Chemotherapy for Falciparum malaria: the armoury, the problems and the prospects, Parasitol Today, 16, 146, 10.1016/S0169-4758(99)01622-1 2010 Yuying, 2008, Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles, J Appl Polym Sci, 107, 891, 10.1002/app.26402